| Targeting Ara h 2 with human‐derived monoclonal antibodies prevents peanut‐induced anaphylaxis in mice M Paolucci, N Wuillemin, V Homère, D Bieli, A Köhli, B Ballmer‐Weber, ... Allergy 78 (6), 1605-1614, 2023 | 10 | 2023 |
| Prion pathogenesis is unaltered in the absence of SIRPα-mediated" don't-eat-me" signaling M Nuvolone, M Paolucci, S Sorce, V Kana, R Moos, T Matozaki, A Aguzzi PloS one 12 (5), e0177876, 2017 | 10 | 2017 |
| Strain matters in mouse models of peanut‐allergic anaphylaxis: Systemic IgE‐dependent and Ara h 2‐dominant sensitization in C3H mice M Paolucci, V Homère, Y Waeckerle‐Men, N Wuillemin, D Bieli, N Pengo, ... Clinical & Experimental Allergy 53 (5), 550-560, 2023 | 6 | 2023 |
| Extended characterization of the novel co-isogenic C57BL/6J Prnp−/− mouse line M Nuvolone, S Sorce, M Paolucci, A Aguzzi Amyloid 24 (sup1), 36-37, 2017 | 6 | 2017 |
| Allergen immunotherapy: progress and future outlook L Šošić, M Paolucci, S Flory, F Jebbawi, TM Kündig, P Johansen Expert Review of Clinical Immunology 19 (7), 745-769, 2023 | 4 | 2023 |
| Kinetics and persistence of anti‐SARS‐CoV‐2 neutralisation and antibodies after BNT162b2 vaccination in a Swiss cohort L Šošić, M Paolucci, A Duda, F Hasler, SM Walton, TM Kündig, ... Immunity, Inflammation and Disease 10 (3), e583, 2022 | 4 | 2022 |
| Multivariate allergen-specific analysis and profiling of serum antibodies from patients with peanut allergy M Paolucci, N Wuillemin, A Köhli, B Ballmer-Weber, Y Severin, ... Clin Exp. Allergy 53 ((3)), 353-358, 2022 | 2 | 2022 |
| BALB/c and C3H mice are both suitable as peanut allergy models PS Krenger, J Sobczak, M Paolucci, TM Kündig, P Johansen, M Vogel, ... Clinical and Experimental Allergy 53 (12), 1310-1313, 2023 | 1 | 2023 |
| Cyclodextrin microneedles for the delivery of a nanoparticle-based peptide antigen vaccine S Geisshüsler, FA Nilsson, N Ziak, Z Kotkowska, M Paolucci, MG Buzhor, ... European Journal of Pharmaceutics and Biopharmaceutics 198, 114249, 2024 | | 2024 |
| A murine model of peanut-allergic asthma M Paolucci, N Antz, V Homère, I Kolm, TM Kündig, P Johansen Frontiers in Allergy 5, 1378877, 2024 | | 2024 |
| MY006: allergen-targeted antibodies for the treatment of peanut allergy C Arena, D Bieli, P Gasser, S Götschi, R Scheibling, T Ilca, M Paolucci, ... Journal of Allergy and Clinical Immunology 153 (2), AB126, 2024 | | 2024 |
| MY006: A passive immunotherapy for the treatment of peanut allergy N Wuillemin, D Bieli, C Arena, S Goetschi, R Scheibling, P Gasser, ... ALLERGY 78, 119-119, 2023 | | 2023 |
| Allergen-targeting antibodies for the treatment of peanut and pollen allergies N Wuillemin, D Bieli, C Arena, P Gasser, S Gotschi, R Scheibling, T Ilca, ... SWISS MEDICAL WEEKLY 153, 5S-5S, 2023 | | 2023 |
| Mapping of IgG-binding epitopes on major birch pollen allergen Bet v 1 for identification of hypoallergenic peptides with potential therapeutic application L Sosic, M Paolucci, D Melillo, A Duda, Y Wackerle-Men, A Streuli, K Eyer, ... SWISS MEDICAL WEEKLY 153, 15S-15S, 2023 | | 2023 |
| Pre-clinical Evaluation of Novel Human-derived Anti-peanut Monoclonal Antibodies for Treatment of Peanut Allergy M Paolucci Universität Zürich, 2023 | | 2023 |
| Kineticsandpersistenceofanti‐SARS‐CoV‐2neutralisation and antibodies after BNT162b2 vaccination in a Swiss cohort L Šošić, M Paolucci, A Duda, F Hasler, SM Walton, TM Kündig, ... | | 2021 |
